Abu Dhabi-based G42 taps out of Cerebras
The California chipmaker is preparing to file for a US IPO as soon as this week, but its plans to go public have been delayed by its G42 ties.
The California chipmaker is preparing to file for a US IPO as soon as this week, but its plans to go public have been delayed by its G42 ties.
Despite controversies and safety concerns, biotech firm Humacyte is pushing its cutting-edge lab-grown blood vessels for uses far beyond what regulators have allowed.
In recent months, the company has ramped up talks with most major podcast companies and top talent.
Mosseri laid out Instagram’s vision for its role on television and the path for its next several years of growth.
There’s little prospect for passage of any legislation that might affect Netflix’s or Paramount’s bids in time.
Drone deliveries are rapidly expanding in India, increasing efficiency but making gig workers nervous that their jobs are being automated.